Skip to content

Clinical trials

Completed Hepatitis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Status: Completed Country / region: Australia Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20122
20135
20171
20181
20191
20201
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences5
Human Genome Sciences Inc.2
Kirby Institute2
Vir Biotechnology, Inc.2
Arbutus Biopharma Corporation1
Brii Biosciences Limited1
GlaxoSmithKline1
Macfarlane Burnet Institute for Medical Research and Public Health Ltd1
Novartis Pharmaceuticals1
Vital Therapies, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis17
Hepatitis B7
Hepatitis B, Chronic6
Hepatitis C6
Hepatitis C, Chronic3
Disease1
Fibrosis1
HIV Infections1
Hepatitis, Chronic1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.